All candidates in Great Britain who faced problems when sitting the General Pharmaceutical Council (GPhC)'s registration assessment will be eligible for
provisional registration, the pharmacy regulator has announced.
However, they are eligible only if they meet eligibility criteria set out in the GPhC policy which states: "Have sat the registration assessment on 29 June 2022
and experienced delays of 30 minutes or more in starting or completing either or both Part 1 and/or Part 2 of the registration assessment due to technical or other
IT difficulties (This also includes those who withdrew from the registration assessment on the day due to the start of the assessment being delayed by 30 minutes or
more)."
GPhC added that these candidates will also be able to claim a full refund, and this sitting will not count as one of their three attempts.
Gisela Abbam, chair of the GPhC, said: "We would like to sincerely apologise again to the candidates who experienced significant problems during their registration
assessment sitting.
The result of the common registration assessment for pharmacists, held jointly by the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of
Northern Ireland (PSNI), have been published with an overall pass rate of 80 per cent.
A total of 2,697 candidates sat the registration assessment in four countries on 29 June and 2,147 candidates passed the assessment.
This summer's pass rate has fallen to 80 per cent compared with the 82 per cent pass rate for the summer 2021 registration assessment, and the 61 per cent pass rate
for the Autumn 2021 registration assessment.
GPhC chief executive Duncan Rudkin said: "We would like to congratulate the successful candidates and we look forward to them joining our register and continuing to
the next stage of their career.
"However, we appreciate that the June registration assessment was a difficult and stressful experience for many - and we are extremely sorry about the problems
faced by a number of candidates on the day.
"For those who did not pass, there is a guide on our website [PDF 255 KB] outlining all the options that may be available, such as provisional registration and
the right to appeal. There are also links to organisations and resources that can provide support with mental health and wellbeing.
The General Pharmaceutical Council (GPhC) has published the results of the common registration assessment for aspiring pharmacists held on 2 November, 2023.
An overall pass rate of 66 per cent was recorded this year, as compared to 56 per cent in 2022 and 61 per cent in 2021.
A total of 1,067 candidates took the registration assessment, held jointly by the GPhC and Pharmaceutical Society of Northern Ireland (PSNI), of which
700 candidates cleared the assessment
In 2022, 937 candidates sat the registration assessment of which 525 passed the assessment.
Commenting on the results, GPhC Director of Education and Standards, Mark Voce, said: "I would like to congratulate all those who passed the November
registration assessment and I look forward to them joining our register to continue to the next stage of their career.
"There will be candidates who unfortunately did not pass the assessment. If this is the case, the information on our website outlines all the possible
options of what to do next.
The General Pharmaceutical Council (GPhC) has appointed a new provider, BTL Group Ltd, to conduct its common registration assessment sittings, which it holds jointly with the Pharmaceutical Society of Northern Ireland (PSNI).
GPhC chief executive, Duncan Rudkin, said: "I'm pleased to confirm that we have appointed BTL as the supplier for the common registration assessment for the next
3 years after a thorough tender process.
"The information provided by BTL during the tender process has given us the necessary assurance that they can support us in continuing to deliver a fair and robust
assessment that tests candidates' ability to register as a pharmacist. We will now work closely with BTL on arrangements for the sittings in 2022, to make sure we can provide a positive experience for candidates."
BTL has extensive experience of delivering services to a range of clients, including the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmology.
Before BTL, GPhC had a contract with Pearson Vue to conduct online assessment in 2021.
Out of the 2,805 students who sat for the common registration assessment test for pharmacists this June, approximately 2,150 have passed the exam, according
to the General Pharmaceutical Council. It assesses pharmacy graduates' knowledge and skills to ensure safe and effective practice as pharmacists.
This year, the pass rate was 77 per cent, slightly lower than the 80 per cent pass rate in June 2022, where 2,147 out of 2,697 candidates cleared the assessment,
GPhC data showed.
The exam comprises a written assessment testing pharmaceutical science and pharmacy practice knowledge and a practical assessment evaluating clinical skills and
patient-facing competencies. Eligible candidates must complete an accredited pharmacy degree program and meet GPhC requirements.
The assessment is conducted jointly by the General Pharmaceutical Council and the Pharmaceutical Society of Northern Ireland.
"The assessment is a primary method for testing trainees' ability to apply knowledge and make professional judgments in pharmacy practice," said Mark Voce, Director
of Education and Standards, GPhC. "This is crucial in assuring patients and the public that they are in safe hands."
Eighty-one per cent of the National Pharmacy Association cohort of trainee pharmacists passed the General Pharmaceutical Council (GPhC)'s common registration assessment which took place in June.
The NPA's team of learning and development pharmacists helped students prepare for the assessment with study days and mock exams.
Celebrating the success of trainee pharmacists, it said: "The 81 per cent NPA pass rate reflected the comprehensive blended learning experience delivered by the
NPA's team of learning and development pharmacists and that we were able to resume face-to-face study days for this cohort after the restrictions of lockdowns."
Last month, the GPhC and Pharmaceutical Society of Northern Ireland (PSNI) published result of the common registration assessment for pharmacists with an overall
pass rate of 80 per cent.
A total of 2,697 candidates sat the registration assessment in four countries on 29 June and 2,147 candidates passed the assessment.
A total of 525 candidates have passed the common registration assessment for pharmacists held in November, the regulators GPhC and PSNI have announced on
Tuesday.
With 937 candidates sitting for the registration assessment, held jointly by the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern
Ireland (PSNI) on 3 November, the pass rate was 56 per cent, down from the 61 per cent for the Autumn 2021.
Among the GPhC candidates, 59 per cent were sitting for the first time, 30 per cent for the second time and 8 per cent for the third time. (The break-up was not
available for the 3 per cent PSNI candidates.)
In comparison, for the June sitting 89 per cent of candidates were sitting for the first time, 7 per cent were sitting for the second time and 4 per cent were
sitting for the third time.
"We would like to congratulate the successful candidates and we look forward to them joining our register and continuing to the next stage of their career,"
Duncan Rudkin, GPhC chief executive said.
In response to stakeholder feedback, the General Pharmaceutical Council (GPhC) is developing a streamlined, single route to registration that will replace
the current multiple-pathway system for overseas pharmacists wishing to practice in Great Britain.
This revised approach will include updated standards for the education and training of internationally qualified pharmacists, with all applicants still required
to pass a registration assessment.
The GPhC's Council intends to streamline the registration pathway, reducing the two-year process to one-year process.
This new pathway will encompass both university study and in-practice training.
Historically, pharmacists qualified within the European Economic Area (EEA) or European Free Trade Association (EFTA) have been eligible for qualification
recognition in Great Britain.
While this recognition has been extended until September 2028, the future requirement for EEA-qualified pharmacists to undergo the new registration route
remains contingent on forthcoming government decisions.
Initially, the GPhC had explored the development of three distinct registration routes for internationally-qualified pharmacists, "however decided to change
this proposed approach after considering feedback from stakeholders."
The General Pharmaceutical Council has apologised for severe delays and disruptions during the June foundation registration assessment at five test centres in
England on Wednesday (June 29).
The pharmacy regulator said it has since "contacted the candidates affected via email to apologise for the disruption and the extra worry this will have caused.
"We will also be issuing our usual survey for all candidates so we can hear directly from them about their experiences and have also asked candidates to get in touch
if they would like individual advice."
GPhC admitted that the worse sufferers were the candidates at a test centre in Nottingham "where the delay was severe and candidates were only able to start Paper 1
in the late afternoon".
Extremely sorry
In a statement, Duncan Rudkin, chief executive of the GPhC, said: "We are extremely sorry for the severe delays experienced by candidates in Nottingham today. This
is completely unacceptable, and we fully appreciate the significant stress and disruption this must have caused for them in such a high-stakes assessment.
While thanking the provisionally registered pharmacists and their employers for supporting NHS services during the pandemic, the General Pharmaceutical Council (GPhC) has asked the 63 eligible candidates to join the main register by January 31 to continue practicing.
A total number of 4,799 provisionally-registered pharmacists have been on the provisional register since it was introduced in July 2020 in response to the Covid-19
pandemic, which had affected the registration assessment schedule.
As of Tuesday (January 18), 237 were still on the provisional register, of which 84 have begun the process to join the main register, 90 did not sat an assessment, while 63 eligible candidates are yet to start their application.
The register enabled trainees who had completed their training to support NHS services and provide patient care effectively as provisionally-registered pharmacists,
while they waited to sit the registration assessment.
After providing three potential opportunities to trainees to sit the registration assessment - in March, July and November 2021, the provisional register will close
on January 31, 2022.
The General Pharmaceutical Council (GPhC) has revealed it has received 25 whistleblowing disclosures between April 2021 and March 2022.
The pharmacy regulator said, in its annual report, that it has concluded enquiries on 22 disclosures so far with a further three still under review.
"We also concluded two qualifying disclosures that were raised during the previous reporting period," it said, adding: "The action GPhC took included a full
investigation through established fitness to practise processes and follow-up action through its inspection network.
"The former can result in any available outcome throughout the fitness to practise process. The latter can include guidance, a follow-up visit or an unexpected
inspection."
12 concerns were investigated and concluded with no further action. Three were signposted to another organisation. The remaining seven cases were concluded by
sharing information with inspection colleagues for follow up action.
Of the two concerns from the previous reporting period, one was concluded with no further action and the other remains under investigation.
The Pharmacists' Defence Association (PDA) has made the its 'Education revision programme' accessible for new registrations who are preparing for the GPhC/PSNI
November 2022 assessment.
The programme offers a wide range of practice calculations questions, some mock exams, practical tips on revision, and an opportunity to chat to other PDA members
who are preparing to sit the assessment.
PDA's charity partners, Pharmacist Support also offer a range of options including- Counselling and peer support; Financial support; A listening friend service and
Addiction support.
Candidates can also access the Wardley Wellbeing Service here. This is a resource to help candidates to prioritise their mental, physical and emotional health
through individual and group training.
The PDA has also reminded all candidates that there have been some changes made by the GPhC to address problems that occurred in the June 2022 sitting.
The Pharmacist' Defence Association (PDA) has welcomed the General Pharmaceutical Council (GPhC) and the Pharmaceutical Society of Northern Ireland (PSNI)'s
plan to ensure a more robust, fair and positive experience for trainees, provisionally registered and potential pharmacists who will be sitting the November 2022
assessment.
"Many candidates at the latest (June 2022) assessment experienced significant delays, technical issues, inadequate invigilation, and disturbances in test centres
around the UK as the newly appointed company BTL ran the high-stakes pharmacist examinations for the first time. The next online exam is due in November 2022 and the
PDA welcome proposed improvements to be introduced before that sitting," said the association.
For some, provisional registration was the accepted response from the GPhC, but for others, such as potential pharmacists who did not want the provisional role,
those unable to find a suitable provisional post, or some that did not meet the criteria for provisional registration, they found themselves in financial
difficulties through no fault of their own, having reasonably expected to have joined the register in the Summer.
The Royal Pharmaceutical Society (RPS) has called for action on differential degree awarding and registration assessment attainment gaps for Black trainees
in initial pharmacy education and training.
According to a new report published by the RPS on Tuesday (6 February), there's a pharmacy degree awarding gap of eight per cent and a registration assessment
attainment gap of over 22 per cent between Black and White trainees.
The variation in pharmacy attainment for Black trainees was first recorded by the General Pharmaceutical Council (GPhC) in 2013, and the Pharmaceutical Journal
has been tracking the awarding gap at undergraduate level.
Even after a decade, significant differences exist in the awarding and attainment gaps for Black students and trainees compared to their White counterparts, the
report said.
The Royal Pharmaceutical Society (RPS) has revealed the "differential attainment" gap among Black pharmacy students and Foundation trainees.
Research conducted by pharmacy education has revealed unique challenges leading to lower attainment in the registration assessment and an undergraduate awards
gap compared to white students.
The organisation plans to work with new groups including BPSA, GPhC, NHS England, Pharmacy Schools Council and representatives from Schools of Pharmacy, to achieve
a fair and equitable education and training experience for the students.
They plan to reach out to student representative organisations to secure their participation in a quarterly meeting of the group.
Differential attainment is the unexplained variation between groups who share a protected characteristic, for example, ethnicity, gender and disability.